| SANTHERA PHARMACEUTICALS |
| Schweiz |
| Gesundheit |
| CH1276028821 / A3EJMQ |
| S3F0 (Frankfurt) |
| FRA:S3F0, ETR:S3F0, S3F0:GR |
| - |
| https://www.santhera.com/ |
|
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating dise..
>Volltext.. |
| 256.98 Mio. EUR |
| 337.81 Mio. EUR |
| 84.77 Mio. EUR |
| -35.28 Mio. EUR |
| -54.07 Mio. EUR |
| -4.19 EUR |
| 107.37 Mio. EUR |
| 24.65 Mio. EUR |
| -38.18 Mio. EUR |
| 0.36 |
| 99.24% |
| -18.44% |
| - |
| - |
| - |
| - |
| SANTHERA |
| 22.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|